Corneal Neovascularization - 20 Studies Found
Completed |
: Photodynamic Therapy With Verteporfin for Corneal Neovascularization : Corneal Neovascularization : 2007-05-08 : Procedure: Photodynamic Therapy with Verteporfin |
Not yet recruiting |
: Subconjunctival Aflibercept (EYLEA®) for the Treatment of Corneal Neovascularization : Corneal Neovascularization : 2016-05-24 : Drug: Aflibercept Other Name: Eylea |
Terminated |
: Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea : Corneal Neovascularization : 2013-05-15 :
|
Withdrawn |
: Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions :
: Drug: Gamunex-C Patients will receive 50 mg (0.5 mL) subconjunctival Gamunex-C injection in addition to |
Completed |
: Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery : Corneal Neovascularization : 2008-10-07 : Drug: Ranibizumab 0.5mg subconjunctival dose of ranibizumab 3 days prior to corneal transplantation and |
Withdrawn |
: Corneal Thinning During Topical Bevacizumab Therapy : Corneal Neovascularization : 2007-08-13 : Drug: bevacizumab (Avastin) |
Recruiting |
: A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival :
: 2013-11-22 :
|
Completed |
: Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival :
: 2010-02-18 :
|
Recruiting |
: Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study :
: 2013-04-26 : Device: Optical Coherence Tomography Imaging of the cornea using ultrahigh resolution Spectral Domain OC |
Completed |
: Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovasculization :
|